Stage IV Childhood Small Noncleaved Cell Lymphoma Completed Phase 1 Trials for Cediranib (DB04849)

IndicationStatusPhase
DBCOND0030352 (Stage IV Childhood Small Noncleaved Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00458731Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaTreatment